This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Lymphotoxin-alpha/TNF-beta Protein
catalog :
211-TBB
quantity :
10 ug (also 50 ug)
price :
239 USD
citations: 5
Reference
Chen J, Liu X, Munshi M, Xu L, Tsakmaklis N, Demos M, et al. BTKCys481Ser drives ibrutinib resistance via ERK1/2, and protects BTKWild-Type MYD88 mutated cells by a paracrine mechanism. Blood. 2018;: pubmed publisher
Sarhan D, Palma M, Mao Y, Adamson L, Kiessling R, Mellstedt H, et al. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β. Eur J Immunol. 2015;45:1783-93 pubmed publisher
Steeland S, Puimège L, Vandenbroucke R, Van Hauwermeiren F, Haustraete J, Devoogdt N, et al. Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1. J Biol Chem. 2015;290:4022-37 pubmed publisher
Yaden B, Wang Y, Wilson J, Culver A, Milner A, Datta Mannan A, et al. Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice. Am J Pathol. 2014;184:1152-66 pubmed publisher
Vang A, Housley W, Dong H, Basole C, Ben Sasson S, Kream B, et al. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac. Biochem J. 2013;456:463-73 pubmed publisher
product information
brand :
R&D Systems
master code :
211-TBB
SKU :
211-TBB-010
product name :
Recombinant Human Lymphotoxin-alpha/TNF-beta Protein
description :
The Recombinant Human Lymphotoxin-alpha/TNF-beta Protein from R&D Systems is derived from E. coli. The Recombinant Human Lymphotoxin-alpha/TNF-beta Protein has been validated for the following applications: Bioactivity.
target :
Lymphotoxin-alpha / TNF-beta
category :
Proteins and Enzymes
unit size :
10 ug (also 50 ug)
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein.
conjugate :
Unconjugated
main entrez gene id :
4049
purity :
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
17-19 kDa, reducing conditions
theoretical molecular weight :
19 kDa
gene symbol :
LTA
details of functionality :
Measured in a cytotoxicity assay using L-929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED50 for this effect is 4-20 pg/mL.
endotoxin note :
<0.01 EU per 1 µg of the protein by the LAL method.
catalog number base :
211-TBB
accessionNumbers :
P01374
applications :
Bioactivity
source :
The Recombinant Human Lymphotoxin-alpha / TNF-beta Protein from R&D Systems is derived from E. coli. The Recombinant Human Lymphotoxin-alpha / TNF-beta Protein has been validated for the following applications: Bioactivity.
USD :
239 USD
alt names :
LT, LTA, LT-alpha, Lymphotoxin alpha, lymphotoxin alpha (TNF superfamily, member 1), Lymphotoxinalpha, tnfb, TNF-beta, TNFBlymphotoxin-alpha, TNFSF1, TNFSF1B, TNFSF1TNF-beta, tumor necrosis factor beta, Tumor necrosis factor ligand superfamily member 1
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.